This is a preview of subscription content, log in via an institution to check access.
Notes
Discrepancy between text (800mg daily) and table (400mg daily).
Reference
Mancuso A, et al. Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients. Alimentary Pharmacology and Therapeutics 38: 1414-1416, No. 11-12, Dec 2013. Available from: URL: http://onlinelibrary.wiley.com/doi/10.1111/apt.12536/pdf - Italy
Rights and permissions
About this article
Cite this article
Antiretrovirals/sorafenib. Reactions Weekly 1502, 7 (2014). https://doi.org/10.1007/s40278-014-0894-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-0894-6